420 with CNW — What Employers Should Know About the Proposed Easing of Federal Cannabis Laws

Cannabis remains listed as a Schedule I substance under the Controlled Substances Act (CSA), a category reserved for drugs considered to have a high likelihood of misuse and no recognized medical purpose. That designation has shaped federal drug policy for decades and continues to influence workplace rules across the country.

In 2023, the Biden administration backed a proposal to shift cannabis to a different category. Last year, President Donald Trump signed an order instructing the Justice Department to move forward with the formal rulemaking process to reclassify cannabis as a Schedule III substance.

Moving marijuana into that group would signal federal recognition that it has accepted medical use in the United States. Such a change could carry significant consequences for workplaces across the country.

For now, however, nothing has officially changed. The federal review is ongoing, and marijuana remains in Schedule I until the process is finalized. Federal rulemaking often moves slowly, and the executive order did not set a clear timeline. Employers should assume that existing federal requirements remain in place.

That means workers in safety-sensitive roles must continue to comply with mandatory drug testing rules. For instance, under the Department of Transportation regulations, employees who perform certain critical duties are prohibited from using cannabis and are subject to routine screening. This includes airline pilots, truck drivers, school bus operators, train engineers, subway operators, aircraft maintenance crews, and armed transit security staff, among others.

Even if cannabis is eventually reclassified, businesses are still expected to retain the authority to enforce policies that ban impairment on the job. Employers would likely continue to conduct drug testing and prohibit on-duty use, provided those policies align with state and local laws.

A shift to Schedule III could also affect disability discrimination claims. More than 35 states have legalized marijuana for medical purposes, yet federal courts have generally dismissed claims under the Americans with Disabilities Act (ADA) tied to medical cannabis use. Judges have pointed to the drug’s current illegal status under federal law as a key reason.

The ADA does offer protections for individuals who use certain controlled substances under a valid prescription. If cannabis gains recognition as an accepted treatment at the federal level, employees may attempt to argue that disciplinary action based solely on medical use violates disability law.

It remains unclear whether such claims would increase significantly, but employers would still be able to address workplace safety concerns. Companies may act if an employee’s use creates a direct safety risk, if the individual is impaired while working, or if a requested accommodation is unreasonable, such as seeking permission to consume marijuana during work hours.

Local and state regulations add another layer of complexity. Even if federal law changes, businesses must comply with rules in the jurisdictions where they operate. Some states provide specific protections for registered medical marijuana patients. In Arizona, for example, the law bars employers from discriminating against workers or applicants solely because they hold a valid medical marijuana card, subject to certain exceptions.

Marijuana companies within and outside the country, such as Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED), will be monitoring how workplaces change their policies once the federal rescheduling is eventually completed and codified.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Texas Grapples with Increasing Cases of Marijuana DUI

As Texas lawmakers review how cannabis is regulated and enforced, safety advocates are drawing attention to what they describe as a mounting and often overlooked risk on the state’s roads: drivers impaired by marijuana. Texans for Safe & Drug Free Youth, a statewide prevention group, argues that limiting access to cannabis products remains the most reliable way to curb use and its consequences.

For years, public awareness campaigns have largely centered on drunk driving. But safety officials warn that marijuana use behind the wheel poses its own dangers. With cannabis becoming more socially accepted, researchers and traffic safety groups say data is beginning to show troubling patterns that require closer scrutiny.

Data from the state Crash Records Information System (CRIS) show that collisions involving drivers impaired by marijuana frequently result in serious harm. On average, 78% of these wrecks lead to death or injury. From 2020 through 2024, 602 persons lost their lives in crashes in which marijuana impairment was identified, an annual average of about 120 fatalities.

Surveys tracking substance use among young people also suggest marijuana remains prevalent among Texas youth and college students. The 2024 Texas School Survey revealed that 7.8% of learners in grades 7 to 12 admitted to using cannabis within the past 30 days. About 13.3% said they had experimented with cannabis, while 25.7% of senior students said they had used marijuana at some point in their lives.

According to the Texas College Survey of 2023, 32.9% of college students in the state said they had experimented with marijuana. Close to 13% reported recent use within the previous month.

Traffic safety experts note that young drivers already face elevated crash risks due to inexperience, and the risk increases when substances are involved. Among drivers aged 25 years or younger who died in crashes, 26% tested positive for both cannabis and alcohol.

Data cited by the Governors Highway Safety Association shows that 25% of seriously injured drivers tested positive for marijuana, compared with 23% for alcohol. In 20% of cases, both substances were detected.

According to Texans for Safe & Drug Free Youth CEO Nicole Holt, the figures should prompt serious discussion. She noted that young adult and teenage brains are still developing, particularly in areas that govern decision-making and impulse control. When marijuana use intersects with driving, she said, the results can be devastating.

Advocates are calling for policies designed to limit youth access and discourage impaired driving. Recommended steps include stricter oversight and enforcement, public education campaigns focused on the risks of drugged driving, prevention programs aimed at adolescents, and continued law enforcement efforts.

It is noteworthy that recreational cannabis is prohibited in Texas, and there are no accurate ways to ascertain that a driver was impaired by marijuana when a crash happened. This is because cannabis metabolites remain detectable in blood days and even weeks after someone consumed marijuana.

Stakeholders in the industry, such as Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), look forward to a time when tools that accurately detect marijuana impairment in drivers are developed and prove their viability in the field.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Virginia Tech Leverages Novel Way to Study Marijuana Effects on Driving

As more states legalize cannabis, researchers are racing to understand what that shift means for road safety. While laws have changed significantly, scientific evidence on how cannabis influences behavior behind the wheel has lagged. A new study led by the Virginia Tech Transportation Institute seeks to close that gap by tracking drivers in their everyday routines.

Over two years, from 2021 through 2023, the research team tracked 105,000 miles driven by adults aged 21 to 70. The trips, 14,700 in total, were recorded using a naturalistic driving approach developed at the institute. About 9,000 miles were logged for marijuana consumption, 1,000 miles reflected alcohol use, while 400 miles included more than one substance use. The remaining trips were substance-free and served as a comparison point for each driver.

According to lead author Kaitlyn Bedwell, the study design allowed researchers to follow individuals over time rather than rely on snapshots. Many earlier studies observed drivers only once or in controlled environments. By contrast, the study tracked how behavior changed across months and years. Bedwell noted that cannabis affects people differently, so observing each participant repeatedly helped capture those differences.

In addition to vehicle data, participants submitted more than 10,000 journal entries describing their substance use. Oral fluid samples were collected regularly to verify those reports.

Preliminary analysis revealed patterns in when and how people drove after using cannabis. Trips linked to cannabis were more common around midday and during evening hours, with Fridays standing out as the most frequent day. Some drivers appeared to adjust their habits, often selecting rural roads instead of busier routes when they had used substances.

Currently, 40 states allow cannabis in some form. While driving while under the influence remains illegal nationwide, measuring marijuana impairment presents challenges. Unlike alcohol, which can be reliably assessed through blood alcohol concentration, there is no roadside tool that can determine whether a driver is under the influence of cannabis.

The primary psychoactive compound in marijuana, tetrahydrocannabinol, behaves differently from alcohol in the body. It dissolves in fat and can remain detectable for weeks after use, long after any intoxicating effects have worn off. Individual factors such as metabolism, body composition, and frequency of use further complicate interpretation. Potency also varies widely across products.

These variables make it difficult to link cannabis levels to crash risk or to craft clear policy guidelines. Bedwell noted that inconsistent findings in past research have added to the uncertainty. She argued that lawmakers need stronger evidence rooted in real-world conditions.

The marijuana ecosystem, including businesses like Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY), hopes that studies of this nature will eventually yield accurate ways to ascertain whether a given driver is or isn’t impaired after using cannabis and getting behind the wheel.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Why Pennies Remain Vital in the Marijuana Industry

For most marijuana retailers, the humble penny has rarely been a topic of concern. That is changing. Earlier this year, President Donald Trump directed the U.S. Mint to halt production of the penny.

Since then, financial institutions have begun limiting the number of pennies they distribute. The shift has drawn little public attention, but businesses that rely heavily on cash are beginning to feel the impact. Cannabis dispensaries are among the first to notice.

Although digital payment tools have expanded in recent years, marijuana sales still involve a significant amount of physical currency. In many states, store owners estimate that about one-third of transactions are settled in cash, though the figure can be higher depending on location and clientele. When exact change becomes difficult to provide, that problem repeats itself at the counter all day.

One purchase, rounded up or down, may seem insignificant. Hundreds in a single day tell a different story.

Without pennies, merchants are advised by the U.S. Treasury to round totals to the nearest nickel. That approach leaves no middle ground. If the final figure is adjusted upward, customers pay slightly more. If it is reduced, the retailer absorbs the shortfall. Over time, those five-cent differences accumulate.

If rounding decisions create a variance of even $15 to $25 each day, the monthly effect becomes noticeable. Over the year, the total can reach into the thousands. For operators managing slim margins, especially in competitive markets with high compliance costs, that sum matters.

Beyond the financial impact, inconsistency is emerging as a concern. Many dispensaries have not formally set a rounding policy. In practice, the decision often falls to individual employees. One cashier may round down, another up. A third might try to balance things based on instinct. The result is uneven treatment at the register and discrepancies in the till.

That inconsistency can complicate bookkeeping. Most point-of-sale systems were designed with exact change in mind. When coins are unavailable, small gaps appear between recorded sales and cash on hand. Drawer shortages become more frequent. Minor sales tax differences surface during reconciliation. None of these issues triggers immediate alarms, but over time, they create irregularities in financial reports.

In the marijuana sector, irregularities attract scrutiny. Regulators, auditors, and financial partners tend to examine even small discrepancies closely. For businesses operating in a tightly regulated environment, added noise in the numbers is unwelcome.

There is also a governance question. If rounding is occurring, it should be clearly documented. Otherwise, it remains unclear who bears the difference and how it is reflected in accounting records. Many existing point-of-sale contracts did not anticipate a scenario in which pennies would be unavailable, and some operators have yet to revisit those arrangements.

Larger metropolitan markets may have more flexibility, including alternative payment options and broader banking relationships. Newer or smaller markets often depend more on lean staffing and cash. In those settings, even modest inconsistencies stand out.

To solve the issue, some retailers have chosen a specific rounding method, configured their systems accordingly, trained employees, and monitored the results. When customers ask about a five-cent adjustment, staff can provide a straightforward explanation.

Others continue to treat the change as a minor nuisance. The same purchase is processed differently depending on who is behind the counter. Over time, those small variations compound, making reconciliation more complex.

The shrinking supply of pennies is not, by itself, a crisis for marijuana businesses. It does, however, highlight how interconnected routine operations can be. Cash management, margin pressures, and compliance requirements already demand careful attention. A small disruption in coin availability can ripple through daily processes more than expected.

For marijuana, the solution is deliberate planning. Establish a clear policy. Implement it consistently. Monitor the numbers. A single coin will not determine a company’s future. But a series of small, unaddressed issues can compound over time, and this is one more factor operators can no longer afford to ignore.

It would be interesting to hear what experience established entities like Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) are having with the shrinking supply of pennies for use during cash transactions.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Study Links Psychiatric Disorders to Adolescent Cannabis Use

Teenagers who use marijuana may be far more likely to develop serious mental health conditions as they move into adulthood, according to a major study released in JAMA Health Forum.

The study tracked 463,396 young people aged 13 to 17 years and followed them until age 26. Investigators found that teens who reported using cannabis within the previous year faced roughly twice the risk of being diagnosed later with psychotic disorders or bipolar disorder. They were also more likely to develop anxiety and depression.

The research team reviewed electronic health records collected during routine pediatric appointments from 2016 through 2023. On average, marijuana use was reported about two years before a psychiatric condition was diagnosed. By examining data over time, researchers were able to observe how substance use and mental health outcomes unfolded, strengthening the argument that adolescent exposure to marijuana may play a role in later illness.

According to one of the study’s authors, Lynn Silver, the results highlight growing concerns as marijuana products become more potent and widely promoted. She noted that bipolar and psychotic disorders are among the most severe psychiatric illnesses and said the data support calls for stronger public health measures.

Those steps could include limiting product potency, restricting marketing aimed at young people, and expanding prevention efforts. She added that marijuana use among teens should be viewed as a health risk rather than dismissed as harmless experimentation.

Marijuana remains the most commonly used illegal substance among U.S. teenagers. A long-running survey shows that use increases as students get older, climbing from about 8% of eighth graders to 26% of high school seniors. Moreover, a 2024 national survey showed that more than one in ten teens aged between 12 and 17 reported using cannabis in the last year.

At the same time, the potency of available products has increased sharply. In California, average THC concentrations in cannabis flower now exceed 20%, far above levels seen decades ago. Concentrated products can reach more than 95% THC.

Unlike earlier research that often focused on heavy consumption or marijuana use disorder, the new study included any self-reported use within the past year. Screening was conducted universally during regular pediatric visits, allowing researchers to capture occasional users as well.

The study also found higher rates of marijuana use among teens covered by Medicaid and those living in economically disadvantaged neighborhoods. Researchers cautioned that expanding commercialization could widen existing mental health gaps if preventive measures are not strengthened.

These findings make a strong case for the control of black market cannabis sellers while allowing licensed companies like TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) that implement age-verification checks to prevent minors from accessing regulated products to flourish.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Florida Supreme Court Considers Appeal to Put Marijuana on State Ballot

Efforts to legalize recreational cannabis in Florida remain active as the state’s highest court weighs whether to take up a key appeal that could determine if voters see the issue on a future ballot.

The Florida Supreme Court is reviewing a request from the Smart and Safe Florida campaign after roughly 71,000 petition signatures were thrown out. If the justices agree to hear the case and ultimately side with the campaign, the proposed constitutional amendment could move forward to the ballot in November.

The group contends that the disputed petitions were improperly invalidated and should be included in the final tally required for ballot access. State officials previously excluded signatures tied to voters listed as inactive, people residing outside Florida, and forms that did not contain the complete wording of the proposed amendment. Campaign organizers say they submitted more than 1.4 million signatures overall, far surpassing the 880,062 required to qualify for placement before voters.

The latest proposal is a revised version of a 2024 amendment that fell short of passage. Although it earned a majority of support at the polls, it did not reach the 60% approval required to amend the state constitution.

In response to concerns raised during that campaign, the updated measure includes new restrictions. It would bar vaping or smoking cannabis in public areas and direct lawmakers to establish rules governing when and where cannabis could be consumed outside private property.

Opposition, however, remains strong. Governor Ron DeSantis, who actively campaigned against the earlier proposal, has argued that the amendment conflicts with the state constitution. Business organizations have also criticized the initiative, contending that outsiders are attempting to use the state’s citizen initiative process for their own gain.

The campaign is also facing legal scrutiny, with state AG Ashley Moody’s office recently launching dozens of criminal investigations tied to alleged fraud in the petition-gathering process.

Subpoenas were issued seeking records from the campaigners as well as from subcontractors involved in collecting signatures. Campaign representatives have denied wrongdoing and said they are cooperating with authorities.

Despite the legal and political obstacles, backers of the initiative say they remain confident. They point to changes made after the 2024 vote and continued support from segments of the marijuana industry as signs that the measure has a viable path forward.

For now, the next move rests with the Florida Supreme Court. Its decision on whether to hear the appeal, and how it rules if the case proceeds, will shape whether voters get another opportunity to weigh in on recreational marijuana in the coming election cycle.

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a company that has heavily invested in efforts to legalize adult-use marijuana, will be closely following what the Supreme Court in the state decides on this matter placed before it.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Massachusetts Considers Freezing Issuance of Marijuana Cultivation Licenses

Cannabis stores across Massachusetts are moving more product than in previous years as the number of licensed businesses reaches a record high in what has become a $1.6 billion annual industry. Even so, regulators are weighing a temporary halt on new cultivation licenses as growers grapple with falling wholesale and retail prices.

Massachusetts, like several other states, is facing a glut of product. That imbalance has driven prices down sharply. Data from the state cannabis commission show that the average cost of an eighth of an ounce dropped to $14.20 last November, a steep decline compared with earlier years of the legal market.

According to commission figures, the state has roughly 1-to-1.2 square feet of approved growing canopy for every adult aged 21 and over. That level of production capacity exceeds what is available in nearby Connecticut, where retail prices remain higher.

Regulators have not yet decided whether to implement a freeze. Commissioners recently voted to schedule a future public hearing to examine the proposal. If approved, the moratorium would apply only to new cultivation applications. Permits that are already in progress would continue moving through the system.

Commissioner Kim Roy indicated that many operators are struggling and suggested that a pause could offer some breathing room. She said businesses across the supply chain, from growers to storefronts, are feeling the strain of tighter margins and intense competition.

The number of active cultivators has already declined. State records show 132 cannabis growers currently operating. At the same time, 158 cultivation licenses have lapsed, and 25 approved license holders have yet to launch operations.

Several multistate cannabis companies have also withdrawn from the state in recent years. In 2023, Trulieve closed its operations in the state while Ayr Wellness shuttered a 217,000-square-foot cultivation facility last summer, marking one of the more visible pullbacks in the market.

Massachusetts does not impose a statewide cap on the number of marijuana licenses. That open structure helped fuel rapid expansion after legalization, but has also contributed to today’s crowded landscape.

Other states have tried limiting new entrants, with mixed outcomes. In Oklahoma, a suspension on new medical marijuana licenses remains in place until August as Governor Kevin Stitt pushes for sweeping changes to the industry.

Meanwhile, Oregon adopted a “one in, one out” approach in 2024, allowing a new cultivation permit only when another operator exits or transfers a license. According to law firm Harris Sliwoski, 24 growers left the Oregon market last year.

Legal marijuana markets everywhere have their own fair share of oversaturation, and many companies like SNDL Inc. (NASDAQ: SNDL) are having to come up with innovative ways to not only survive but also thrive under the challenging conditions in the jurisdictions where they have operations.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Virginia Cannabis Sales Bill Moves to Senate Floor for Consideration

Virginia legislators have moved closer to creating a legal retail cannabis market, advancing a revised Senate proposal. The updated bill cleared the Senate Finance and Appropriations Committee on a 7 to 5 vote, sending it to the full Senate for debate. Meanwhile, House members are preparing to debate their companion bill.

Virginia legalized possession of small amounts of cannabis and limited home cultivation in 2021. Lawmakers have since worked to establish a system for commercial sales, but previous efforts were blocked by former Governor Glenn Youngkin, who vetoed legislation that would have created a retail framework.

Although the Senate and House bills share the same goal of allowing adults to purchase cannabis legally, they differ in several important areas. Those differences will need to be resolved before any final measure can reach the governor’s desk.

Among the changes adopted in the Senate panel was an increase in the fee required for existing medical cannabis operators to enter the adult-use market. Under the revised language, those businesses would pay $15 million for a conversion license. The proposal also sets a combined tax rate of 17% on marijuana products.

The Senate version would also restructure oversight of the industry. It proposes folding the Cannabis Control Authority into the Alcoholic Beverage Control Authority, creating a single entity called the Alcoholic Beverage and Cannabis Control Authority. The House plan keeps marijuana regulation under the existing Cannabis Control Authority.

Other amendments address banking access for cannabis businesses, ban online sales, and establish new requirements for background checks, product packaging, registration, and application timelines.

Notably, senators removed several criminal penalties that had been added by another committee earlier in the process. Those provisions would have imposed sanctions on individuals who purchased marijuana from unlicensed sellers, reinstated penalties for possession by individuals under 21, and increased consequences for illegal sales.

Under both current proposals, adults could buy up to 2.5 ounces of cannabis per transaction, or an equivalent amount in other products as determined by officials. The House measure sets Nov. 1 as the start date for retail sales, while the Senate measure targets January next year.

Revenue from marijuana taxes would be directed toward regulatory costs, early childhood education, public health initiatives, substance use treatment, and a fund aimed at reinvesting in communities disproportionately affected by past drug enforcement policies.

Both versions also require cannabis companies to enter into labor peace agreements. In addition, a legislative commission would study the possibility of licenses for on-site consumption and temporary event sales.

Governor Abigail Spanberger, who recently took office, has voiced support for establishing a recreational cannabis market. Marijuana industry actors like Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) around the country will be hoping that a legal market for adult-use cannabis finally launches in Virginia.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Illinois Still Struggles to Clear Old Marijuana Criminal Records

For decades, a cannabis conviction from 1980 trailed Roosevelt Myles, lingering on his record long after he served his time. Myles, an Illinois resident, spent nearly three decades behind bars for a murder he maintained he did not commit. An appellate court later overturned the conviction, and a judge granted him a certificate of innocence after finding no physical evidence connected him to the crime.

When he was released in 2020, Illinois had already legalized recreational cannabis and created a process to clear certain marijuana offenses. With help from attorneys at New Leaf Illinois, an online resource that assists with record clearing, Myles petitioned to seal his cannabis conviction and expunge the wrongful murder charge. Last fall, a judge approved both requests.

Earlier that year, Myles said he was turned down for a job due to his criminal history. The court’s decision felt like a major step forward after what he described as reaching his lowest point.

His case, however, stands in contrast to statewide trends. Research from the Paper Prisons Initiative estimates that about 2.2 million Illinois residents were eligible to clear or seal their records in 2021. Yet only around one in ten had filed the necessary paperwork.

Advocates cite several obstacles for this gap, including limited awareness, court costs, prolonged wait times, and fear of navigating the legal system. Lawmakers hope the recently approved Clean Slate Act will help. Beginning in 2029, the law will automatically seal eligible nonviolent records for more than 1.7 million people.

Not all legislators supported the change, however. Senator Steve McClure argued that automatic sealing could prevent employers and families from accessing important background information, particularly in cases involving financial abuse of older adults.

Even after a judge signs an order, records are not always updated right away. By law, agencies have 60 days from the date of receiving a court order to comply, but delays are common. Myles said that although his sealing order was approved in October 2025, he has yet to receive confirmation from the state police that his record has been changed. Until the state’s criminal history database reflects the change, background checks may still show the old charges.

Meanwhile, the federal government is considering reclassifying cannabis to acknowledge its medical use and lower potential for abuse. Legal experts say that the shift would not change eligibility rules in Illinois, since record clearing is governed by state law.

Some argue that federal reclassification could impact contested cases, particularly in counties where judges are more likely to be skeptical of expungement requests. Still, they emphasize that meaningful relief depends on efficient implementation at the state level.

For Myles, recent reforms offer hope, but closure remains out of reach as long as his records remain in limbo.

Marijuana businesses like Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) based on Illinois and those operating in other states with legal marijuana markets will be hoping that laws requiring the expungement of certain cannabis-linked crimes are swiftly implemented in the spirit of providing restorative justice now that drug laws have evolved.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Kentucky Officials Ask Lawmakers to Expand Medical Marijuana Program

Kentucky marijuana officials are urging lawmakers to broaden the list of medical conditions that qualify patients for a medical cannabis card. In a letter sent Thursday to top legislative leaders, the OCM outlined its case for expanding eligibility under the state’s relatively new program.

At present, Kentuckians can seek a medical cannabis card if they have been diagnosed with chronic pain, cancer, persistent nausea, PTSD, epilepsy, or multiple sclerosis. The OCM now wants to add 16 additional diagnoses to that list, a move it says would significantly increase access for patients across the commonwealth.

The proposed additions include amyotrophic lateral sclerosis, irritable bowel disease, Parkinson’s disease, Crohn’s disease, sickle cell anemia, ulcerative colitis, cachexia, neuropathies, fibromyalgia, arthritis, muscular dystrophy, HIV, AIDS, Huntington’s disease, glaucoma, and terminal illnesses.

Agency officials estimate that expanding eligibility could open the program to roughly 430,000 more residents.

Advocates for cannabis policy reform are also backing the change. According to Dr. Jeremy Haysley, medical director of the Kentucky Medical Marijuana Center, adding more clearly defined conditions would help remove uncertainty for people who are unsure whether their diagnosis meets current standards. Haysley’s clinic assists patients in obtaining cannabis certifications.

Matthew Bratcher, executive director of Kentucky NORML, said broader access could offer relief to people living with long-term or debilitating illnesses. He pointed to the potential for cannabis to serve as an alternative to opioid medications, which have contributed to addiction and overdose crises in the state.

Even so, Bratcher acknowledged that lawmakers may take a cautious approach. He said it is possible the General Assembly will wait until the medical marijuana program has operated for at least a year and participation numbers are clearer before approving additional conditions.

Kentucky legalized medical cannabis in 2023 when legislators passed Senate Bill 47, setting up the regulatory framework for cultivation, sales, and patient access. The first dispensary opened its doors in December 2025, and several more locations have since begun operating statewide.

House Bill 401, sponsored by Rep. Al Gentry, would expand the list of qualifying medical conditions, along with other adjustments to the program. In a statement, Gentry said the time has come to ensure that patients who need cannabis for legitimate medical reasons are not left out.

He added that he plans to introduce two measures this session aimed at widening access and called on fellow lawmakers to support the effort. The broader marijuana industry, including established businesses like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF), will be glad when Kentucky lawmakers agree to let more patients gain access to medical marijuana.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com